Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prophylactic transfusion prevents strokes in children with sickle cell anemia who have abnormalities on transcranial Doppler ultrasonographic examination. However, it is not known how long transfusion should be continued in these children. METHODS: We studied children with sickle cell disease who had a high risk of stroke on the basis of a transcranial Doppler screening examination and who had received transfusions for 30 months or longer, during which time the Doppler readings became normal. The children were randomly assigned to continued transfusion or no continued transfusion. Children with severe stenotic lesions on cerebral magnetic resonance angiography were excluded. The composite primary end point was stroke or reversion to a result on Doppler examination indicative of a high risk of stroke. RESULTS: The study was stopped after 79 children of a planned enrollment of 100 underwent randomization. Among the 41 children in the transfusion-halted group, high-risk Doppler results developed in 14 and stroke in 2 others within a mean (+/-SD) of 4.5+/-2.6 months (range, 2.1 to 10.1) of the last transfusion. Neither of these events of the composite end point occurred in the 38 children who continued to receive transfusions. The average of the last two transcranial Doppler results before transfusion was started was the only predictor of the composite end point (P=0.05). CONCLUSIONS: Discontinuation of transfusion for the prevention of stroke in children with sickle cell disease results in a high rate of reversion to abnormal blood-flow velocities on Doppler studies and stroke. (ClinicalTrials.gov number, NCT00006182.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the approximately 22% of children who did not achieve normalization of transcranial Doppler velocity in spite of optimal transfusion in the trial were also protected from stroke (162).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [162]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Research works printed but not linked: 2
- Ohene-Frempong K, 1998, Blood, 91, 288
- Walters MC, 2000, Blood, 95, 1918
Cited by
Items 301–400 of 665
AlMozain, N., Elobied, Y., Al-Omran, A., Aljaloud, A., Omair, A. I. B., Tuwaim, R. B., Alkhalifah, S., Altawil, E., Abraham, S., Salcedo, L. R., et al. (2022) · Asian Journal of Transfusion Science · doi:10.4103/ajts.ajts_13_21 · Cited by 15
Aldana, P. R., Hanel, R. A., Piatt, J. H., Han, S. H., Bansal, M. M., Schultz, C. L., Gauger, C. A., Pederson, J. M., Wellons, J. C., Hulbert, M. L., et al. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30336 · Cited by 15
Vasculopathie cérébrale de l’enfant drépanocytaire : points clés et nouveautés
Corvest, V., Blais, S., Dahmani, B., de Tersant, M., Etienney, A.-C., Maroni, A., Ormières, C., Roussel, A. M., & Pondarré, C. (2017) · Archives de Pédiatrie · doi:10.1016/j.arcped.2017.11.015 · Cited by 15
Al‐Riyami, A. Z., & Daar, S. (2018) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2018.18.01.002 · Cited by 15
Recommendations for the use of red blood cell exchange in sickle cell disease
Fort, R. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.03.004 · Cited by 15
Lobo, C. L. D. C., Ângulo, I. L., Aparicio, L. R., Drelichman, G. I., Zanichelli, M. A., Cançado, R. D., & on behalf of the RELATH Investigators (2011) · Hematology · doi:10.1179/102453311x13085644680302 · Cited by 15
Erythrocytapheresis: Do Not Forget a Useful Therapy!
Ullrich, H., Fischer, R., Grosse, R., Kordes, U., Schubert, C., Altstadt, B., & Andreu, G. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000112044 · Cited by 15
Current Concepts in Pediatric Stroke
Andrade, A., Yau, I., & Moharir, M. D. (2014) · The Indian Journal of Pediatrics · doi:10.1007/s12098-014-1604-3 · Cited by 15
The prevention and management of stroke in sickle cell anaemia
Qureshi, N. A., Lubin, B. H., & Walters, M. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1087 · Cited by 15
How I manage sickle cell patients with high transcranial doppler results
Brewin, J. N., Kaya, B., & Chakravorty, S. (2017) · British Journal of Haematology · doi:10.1111/bjh.14850 · Cited by 14
The Evolving Landscape of Drug Therapies for Sickle Cell Disease
Rai, P., Desai, P. C., & Ataga, K. I. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.008 · Cited by 14
Fasano, R. M., Paul, W., Siegal, E., & Luban, N. L. C. (2012) · Immunohematology · doi:10.21307/immunohematology-2019-142 · Cited by 14
Terrell, D. L., Savardekar, A. R., Whipple, S. G., Dossani, R. H., Spetzler, R. F., & Sun, H. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.01.182 · Cited by 14
Treatment of arterial ischemic stroke in children
Carpenter, J. L., Tsuchida, T. N., & Lynch, J. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.383 · Cited by 14
Cerebrovascular disease in sickle cell disease
Alakbarzade, V., Maduakor, C., Khan, U., Khandanpour, N., Rhodes, E., & Pereira, A. C. (2022) · Practical Neurology · doi:10.1136/pn-2022-003440 · Cited by 14
Stroke without cerebral arteriopathy in sickle cell disease children: causes and treatment
Linguet, S. L., Verlhac, S., Missud, F., Holvoet, L., Brousse, V. A. M., Ithier, G., Ntorkou, A. A., Lesprit, E., Benkerrou, M., Kossorotoff, M., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.283773 · Cited by 13
Acute lobar nephritis in children: Not so easy to recognize and manage
Bibalo, C., Apicella, A., Guastalla, V., Marzuillo, P., Zennaro, F., Tringali, C., Taddio, A., Germani, C., & Barbi, E. (2016) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v5.i1.136 · Cited by 13
Alboog, A. S., Tayeb, T. M., Alsager, M. O., Alnajjar, S. A., Damanhouri, G. A., Jarullah, J. S., & Hindawi, S. (2015) · Journal of King Abdulaziz University-Medical Sciences · doi:10.4197/med.22-3.5 · Cited by 13
Estepp, J. H., Cong, Z., Agodoa, I., Kang, G., Ding, J., McCarville, M. B., Hankins, J. S., & Wang, W. C. (2021) · British Journal of Haematology · doi:10.1111/bjh.17620 · Cited by 13
Hussain, S., Nichols, F. T., Bowman, L., Xu, H., & Neunert, C. E. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25306 · Cited by 13
Barrett, K. M., & Meschia, J. F. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000446109.20539.68 · Cited by 13
Adami, F., Briani, C., Binotto, G., Altinier, S., Tarantini, G., & Semenzato, G. (2009) · American Journal of Hematology · doi:10.1002/ajh.21581 · Cited by 13
Vascular Diseases of the Nervous System
Golomb, M. R., & Biller, J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00065-7 · Cited by 13
AIUM Practice Parameter for the Performance of Transcranial Doppler Ultrasound
(2023) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16234 · Cited by 12
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial
Nieves, R. M., Latham, T., Marte, N. M., Berges, M. E., Sánchez, L. M., Urcuyo, G. S., Florencio, C., Gonzalez, C., Villar, P. D., Chen, S., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014327 · Cited by 12
Red blood cell exchange techniques and methods
Driss, F., & Héquet, O. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.03.005 · Cited by 12
Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study
Gargot, J., Parriault, M.-C., Adenis, A., Clouzeau, J., Van, K.-A. D., Ntab, B., Defo, A., Nacher, M., & Elenga, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.851918 · Cited by 12
The evolving treatment landscape for children with sickle cell disease
Jacob, S. A., Talati, R., & Kanter, J. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(23)00201-8 · Cited by 12
Kim, M. S., & Prasad, V. K. (2025) · American Journal of Hematology · doi:10.1002/ajh.27635 · Cited by 12
The role of blood transfusion in Sickle Cell Disease
Howard, J. (2013) · ISBT Science Series · doi:10.1111/voxs.12047 · Cited by 12
Advances in Sickle Cell Disease Management
Engel, E. R., Howard, A., Ankus, E. J., & Rico, J. F. (2020) · Advances in Pediatrics · doi:10.1016/j.yapd.2020.03.001 · Cited by 12
Transfusion support: Considerations in pediatric populations
McCormick, M. C., & Delaney, M. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.07.003 · Cited by 12
Pediatric transfusion medicine: development of a critical mass
Hillyer, C. D., Mondoro, T. H., Josephson, C. D., López-Sánchez, R. C., Sloan, S. R., & Ambruso, D. R. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.02015.x · Cited by 12
Sabarense, A. P., Silva, C. M., Muniz, M. B. D. S. R., & Viana, M. B. (2021) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2021.05.001 · Cited by 12
Brain Age Modeling and Cognitive Outcomes in Young Adults With and Without Sickle Cell Anemia
Ford, A. L., Fellah, S., Wang, Y., Unger-Levinson, K., Hagan, M., Reis, M. N., Mirro, A. E., Lewis, J. B., Ying, C., Guilliams, K. P., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.53669 · Cited by 11
Utsugisawa, T., & Kanno, H. (2022) · Japanese Journal of Transfusion and Cell Therapy · doi:10.3925/jjtc.68.3 · Cited by 11
Mozaffarzadeh, M., Verweij, M. D., de Jong, N., & Renaud, G. (2022) · Applied Sciences · doi:10.3390/app121910183 · Cited by 11
Hemorrhagic stroke in children
Askarova, A. E., & Zhurkabayeva, B. D. (2024) · Journal of Central Nervous System Disease · doi:10.1177/11795735241289913 · Cited by 11
Arterial ischemic stroke in children - Recent advances
Mallick, A. A., & Ganesan, V. (2008) · The Indian Journal of Pediatrics · doi:10.1007/s12098-008-0239-7 · Cited by 11
Ischemic stroke in a child mistaken as functional disorder
Agrawal, A., Joharapurkar, S. R., & Gharde, P. (2007) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.07.007 · Cited by 11
The clinical care of adult patients with sickle cell disease
Olujohungbe, A., & Howard, J. (2008) · British Journal of Hospital Medicine · doi:10.12968/hmed.2008.69.11.31646 · Cited by 11
Management of sickle cell disease: challenges and risks of transfusion
Serjeant, G. R. (2016) · International Journal of Clinical Transfusion Medicine · doi:10.2147/ijctm.s96918 · Cited by 11
Karafin, M. S., Carpenter, E. L., Pan, A. Y., Simpson, P. M., & Field, J. J. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.01.008 · Cited by 11
The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia
Amlie‐Lefond, C., Flanagan, J. M., Kanter, J., & Dobyns, W. B. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.06.004 · Cited by 11
Red blood cell exchange in children and adolescents with sickle cell disease
Merlin, É., Héquet, O., & Kanold, J. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.03.006 · Cited by 11
More Blood for Sickle Cell Anemia?
Steinberg, M. H. (2014) · New England Journal of Medicine · doi:10.1056/nejme1405776 · Cited by 11
Therapeutics for sickle cell disease intravascular hemolysis
Xue, J., & Li, X. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1474569 · Cited by 10
Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations
Sharma, A., Dahiya, A., Alavi, A., Woldie, I., Sharma, A., Karson, J., & Singh, V. (2024) · Hemato · doi:10.3390/hemato5010004 · Cited by 10
Toward a Stroke-Free Childhood in Sickle Cell Disease: The 2013 Sherman Lecture
Adams, R. J. (2013) · Stroke · doi:10.1161/strokeaha.113.001312 · Cited by 10
Intellectual impairment and TCD evaluation in children with sickle cell disease and silent stroke
Onofri, A., Montanaro, M., Rampazzo, P., Colombatti, R., Farina, F. M., Manara, R., Sainati, L., Ermani, M., Baracchini, C., & Meneghetti, G. (2012) · Perspectives in Medicine · doi:10.1016/j.permed.2012.02.006 · Cited by 10
Jeste, N. D., Sánchez, L. M., Urcuyo, G. S., Berges, M. E., Luden, J., Stuber, S. E., Latham, T., Mena, R., Nieves, R. M., & Ware, R. E. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7491 · Cited by 10
Oral health considerations for pediatric patients with sickle cell disease
Alrayyes, S. M., Compton, A.-A., & Kawar, N. I. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.12.006 · Cited by 10
Sickle Cell Disease and Stroke
Krejza, J., Świat, M., Tomaszewski, M., & Melhem, E. R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0922-0_5 · Cited by 10
Ballas, S. K. (2017) · Transfusion · doi:10.1111/trf.14154 · Cited by 10
Cerebral Infarction in Children with Sickle Cell Disease: A Concise Overview
Musallam, K. M., Khoury, R. A., & Abboud, M. R. (2011) · Hemoglobin · doi:10.3109/03630269.2011.621148 · Cited by 10
Rabinstein, A. A., & Resnick, S. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7506-7537-6.50013-5 · Cited by 10
Deferasirox for managing transfusional iron overload in people with sickle cell disease
Meerpohl, J. J., Antes, G., Rücker, G., Fleeman, N., Niemeyer, C. M., & Bassler, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007477.pub2 · Cited by 10
Ebeid, F. S. E. (2023) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2023.103719 · Cited by 9
Biomarkers and recent advances in the management and therapy of sickle cell disease
Telen, M. J. (2015) · F1000Research · doi:10.12688/f1000research.6615.1 · Cited by 9
DeBaun, M. R., & King, A. A. (2016) · Hematology · doi:10.1182/asheducation-2016.1.632 · Cited by 9
Manzano-Núñez, R., Figueroa, C., & García‐Perdomo, H. A. (2019) · Journal of Child Health Care · doi:10.1177/1367493518814922 · Cited by 9
Oyedeji, C. I., Crawford, R. D., & Shah, N. (2020) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.08.007 · Cited by 9
Clinical and Pathophysiological Aspects of Sickle Cell Anemia
Steinberg, M. H., Ohene‐Frempong, K., & Heeney, M. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.027 · Cited by 9
Mian, H. S., Ward, R. A., Telfer, P. T., Kaya, B., & Kuo, K. H. M. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1057734 · Cited by 9
Advances in transcranial Doppler clinical applications
Topçuoğlu, M. A., Unal, A. U., & Arsava, E. M. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2010.495749 · Cited by 9
Cerebrovascular Disease in Children
Kirton, A., & deVeber, G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00100-1 · Cited by 9
Mukherjee, S., Sahu, A., Ray, G. K., Maiti, R., & Prakash, S. (2022) · Vox Sanguinis · doi:10.1111/vox.13288 · Cited by 8
Abnormalities of the structure and synthesis of hemoglobin
Thein, S. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00009-2 · Cited by 8
Sayin, E. S., Sobczyk, O., Poublanc, J., Mikulis, D. J., Fisher, J. A., Kuo, K. H. M., & Duffin, J. (2022) · Physiological Reports · doi:10.14814/phy2.15472 · Cited by 8
Rankin, A. W., Darbari, D. S., Campbell, A., Webb, J. L., Mo, Y. D., Jacquot, C., Delaney, M., Luban, N. L. C., & Nickel, R. S. (2021) · Transfusion · doi:10.1111/trf.16444 · Cited by 8
Peine, B., Callaghan, M. U., Callaghan, J. H., & Glaros, A. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123491 · Cited by 8
Blood Components and Fractionated Plasma Products: Preparation, Indications and Administration
Robitaille, N., & Hume, H. A. (2006) · Wiley eBooks · doi:10.1002/9780470987001.ch32 · Cited by 8
Current strategies for the management of children with sickle cell disease
de Montalembert, M. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.33 · Cited by 8
Ganesan, V. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.14 · Cited by 8
Transcranial Doppler Sonography
Barlinn, K., & Alexandrov, A. V. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4005-4_10 · Cited by 8
Saunthararajah, Y., & Vichinsky, E. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00042-1 · Cited by 8
Rapid healing of a late diagnosed sickle cell leg ulcer using a new combination of treatment methods
Schleucher, R. D., Gaessler, M., & Knobloch, J. (2007) · Journal of Wound Care · doi:10.12968/jowc.2007.16.5.27036 · Cited by 8
Children’s National Medical Center’s transfusion protocol for sickle hemoglobinopathies
Minniti, C. P., Kratovil, T., & Luban, N. L. C. (2006) · Immunohematology · doi:10.21307/immunohematology-2019-367 · Cited by 8
Howard, J., & Davies, S. C. (2007) · Paediatrics and Child Health · doi:10.1016/j.paed.2007.05.001 · Cited by 8
Yee, M. E. M., Covington, M. L., Zerra, P. E., McCoy, J. W., Easley, K. A., Joiner, C. H., Bryksin, J., Francis, R. O., Lough, C. M., Patel, N., et al. (2024) · Transfusion · doi:10.1111/trf.17857 · Cited by 7
Jacobs, J. W., Amorim, L., Pirenne, F., Tagny, C. T., Adimora, I., Pecker, L. H., Tobian, A. A. R., Callum, J. L., Makani, J., Gladwin, M. T., et al. (2025) · British Journal of Haematology · doi:10.1111/bjh.20055 · Cited by 7
Sickle cell anaemia: Current therapies
Vermylen, C. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.07.018 · Cited by 7
Brain‐derived neurotrophic factor levels in pediatric sickle cell disease
Lance, E. I., Barron‐Casella, E. A., Everett, A. D., & Casella, J. F. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28076 · Cited by 7
Karkoska, K. A., & McGann, P. T. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29363 · Cited by 7
Coagulation Abnormalities in Stroke
Brey, R. L., & Coull, B. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50040-7 · Cited by 7
Transfusions for patients with sickle cell disease at Children’s Hospital Boston
Sloan, S. R. (2012) · Immunohematology · doi:10.21307/immunohematology-2019-143 · Cited by 7
Bernaudin, F., & Verlhac, S. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32688-3 · Cited by 7
Ischemic Stroke in Children and Young Adults with Sickle Cell Disease (SCD) in the Post-STOP Era
Kwiatkowski, J. L., Kanter, J., Fullerton, H. J., Voeks, J. H., Debenham, E., Brown, D. G., Brown, L., & Adams, R. J. (2015) · Blood · doi:10.1182/blood.v126.23.68.68 · Cited by 7
Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials
Mercier‐Ross, J., Forté, S., & Soulières, D. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2105835 · Cited by 6
Transfusion and Iron Chelation Therapy in Thalassemia and Sickle Cell Disease
Kwiatkowski, J. L., & Porter, J. B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.040 · Cited by 6
Anemia de células falciformes: Guía de manejo pediátrico
Bello, A. C. (2012) · Archivos Venezolanos de Puericultura y Pediatría · Cited by 6
Single Gene Disorders Associated With Stroke: A Review and Update on Treatment Options
Muqtadar, H., & Testai, F. D. (2012) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0179-4 · Cited by 6
Lance, E. I., Faulcon, L. M., Fu, Z., Yang, J., Whyte‐Stewart, D. A., Strouse, J. J., Barron‐Casella, E. A., Jones, K., Eyk, J. E. V., Casella, J. F., et al. (2021) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202100003 · Cited by 6
Wade, J., Yee, M. E. M., Easley, K. A., Pahz, S., Butler, H., Zerra, P. E., Josephson, C. D., & Fasano, R. M. (2022) · Transfusion · doi:10.1111/trf.16807 · Cited by 6
Sickle Cell Disease in Brazil: Current Management
Araújo, A. D. S., Pinto, A. C. S., Lobo, C. L. D. C., Figueiredo, M. S., Gualandro, S. F. M., Saad, S. T. O., & Cançado, R. D. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2344790 · Cited by 6
Verlhac, S. (2008) · Archives de Pédiatrie · doi:10.1016/s0929-693x(08)71858-x · Cited by 6
Case 10-2016: A 22-Year-Old Man with Sickle Cell Disease, Headache, and Difficulty Speaking
Buonanno, F. S., Schmahmann, J. D., Romero, J. M., & Makar, R. S. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcpc1501148 · Cited by 6
Building a Career as a Pediatric Stroke Neurologist
Fullerton, H. J., Ganesan, V., Jordan, L. C., Kirton, A., Mackay, M. T., & Steinlin, M. I. (2019) · Stroke · doi:10.1161/strokeaha.119.026187 · Cited by 6
Maxwell, L. G., Goodwin, S. R., Mancuso, T. J., Baum, V. C., Zuckerberg, A. L., Morgan, P. G., Motoyama, E. K., Davis, P. J., & Sullivan, K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06612-9.00036-5 · Cited by 6
Cord blood transplantation for sickle cell anemia: Bust or boom?
Walters, M. C. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00757.x · Cited by 6
Metadata
- Authors
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Affiliations
- Augusta University (US)
- Corresponding author
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-29
- Volume
- 353
- Issue
- 26
- Pages
- 2769-2778
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1498156640
- Cited by
- 635
- References
- 27
- Citations by year
- 2026: 23 · 2025: 12 · 2024: 31 · 2023: 22 · 2022: 29 · 2021: 27 · 2020: 34 · 2019: 25 · 2018: 35 · 2017: 37 · 2016: 43 · 2015: 25 · 2014: 32 · 2013: 32 · 2012: 45
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL052193, U01HL052016)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, stroke prevention, prophylactic transfusion, transcranial Doppler screening, cerebral blood flow velocity, children
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Flow Velocity, Blood Transfusion, Brain, Child, Female, Humans, Magnetic Resonance Imaging, Male, Risk, Chelation Therapy, Ultrasonography, Doppler, Transcranial, Stroke, Middle Cerebral Artery, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.